Local anesthetics and immunotherapy: a novel combination to fight cancer

Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P et al (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334(6062):1573–1577. https://doi.org/10.1126/science.1208347 Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72. https://doi.org/10.1146/annurev-immunol-032712-100008 Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13(9):1050–1059. https://doi.org/10.1038/nm1622 Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S et al (2014) Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ 21(1):79–91. https://doi.org/10.1038/cdd.2013.75 Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C et al (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15(10):1170–1178. https://doi.org/10.1038/nm.2028 Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC et al (2009) Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 28(5):578–590. https://doi.org/10.1038/emboj.2009.1 Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13(1):54–61. https://doi.org/10.1038/nm1523 Bezu L, Sauvat A, Humeau J, Gomes-da-Silva LC, Iribarren K, Forveille S et al (2018) eIF2alpha phosphorylation is pathognomonic for immunogenic cell death. Cell Death Differ 25(8):1375–1393. https://doi.org/10.1038/s41418-017-0044-9 Korbelik M, Zhang W, Merchant S (2011) Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer immunology, immunotherapy : CII 60(10):1431–1437. https://doi.org/10.1007/s00262-011-1047-x Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2012) Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother : Cii 61(2):215–221. https://doi.org/10.1007/s00262-011-1184-2 Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M et al (2008) The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 15(9):1499–1509. https://doi.org/10.1038/cdd.2008.67 Reschke R, Gajewski TF (2022) CXCL9 and CXCL10 bring the heat to tumors. Science immunology 7(73):1–3. https://doi.org/10.1126/sciimmunol.abq6509 Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D et al (2016) Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis. Can Res 76(7):1746–1756. https://doi.org/10.1158/0008-5472.CAN-15-1142 Kaufman HL, Kohlhapp FJ, Zloza A (2015) Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov 14(9):642–662. https://doi.org/10.1038/nrd4663 Chesney J, Puzanov I, Collichio F, Singh P, Milhem MM, Glaspy J et al (2018) Randomized, open-label phase II study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma. J Clin Oncol : Off J Am Soc Clin Oncol 36(17):1658–1667. https://doi.org/10.1200/JCO.2017.73.7379 Yu Z, Geng J, Zhang M, Zhou Y, Fan Q, Chen J (2014) Treatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell death. Oncotarget 5(15):6526–6539. https://doi.org/10.18632/oncotarget.2310 Tselikas L, Dardenne A, de Baere T, Faron M, Ammari S, Farhane S et al (2022) Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy’s initial experience with its first 100 patients. Eur J Cancer 172:1–12. https://doi.org/10.1016/j.ejca.2022.05.024 Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C et al (2018) Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med 24(12):1845–1851. https://doi.org/10.1038/s41591-018-0232-2 Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O et al (2017) Oncolytic virotherapy promotes intratumoral t cell infiltration and improves Anti-PD-1 immunotherapy. Cell 170(6):1109-19e10. https://doi.org/10.1016/j.cell.2017.08.027 Shi L, Chen L, Wu C, Zhu Y, Xu B, Zheng X et al (2016) PD-1 Blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor. Clin Cancer Res : Off J Am Assoc Cancer Res 22(5):1173–1184. https://doi.org/10.1158/1078-0432.CCR-15-1352 Kleinovink JW, Fransen MF, Lowik CW, Ossendorp F (2017) Photodynamic-immune checkpoint therapy eradicates local and distant tumors by CD8(+) T cells. Cancer Immunol Res 5(10):832–838. https://doi.org/10.1158/2326-6066.CIR-17-0055 O’Shaughnessy MJ, Murray KS, La Rosa SP, Budhu S, Merghoub T, Somma A et al (2018) Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors. Clin Cancer Res : Off J Am Assoc Cancer Res 24(3):592–599. https://doi.org/10.1158/1078-0432.CCR-17-0186 Waitz R, Solomon SB, Petre EN, Trumble AE, Fasso M, Norton L et al (2012) Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Can Res 72(2):430–439. https://doi.org/10.1158/0008-5472.CAN-11-1782 Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G et al (2015) Assessing a novel immuno-oncology-based combination therapy: ipilimumab plus electrochemotherapy. Oncoimmunology 4(6):e1008842. https://doi.org/10.1080/2162402X.2015.1008842 Taylor A, McLeod G (2020) Basic pharmacology of local anaesthetics. BJA education 20(2):34–41. https://doi.org/10.1016/j.bjae.2019.10.002 Heavner JE (2007) Local anesthetics. Curr Opin Anaesthesiol 20(4):336–342. https://doi.org/10.1097/ACO.0b013e3281c10a08 Bourne E, Wright C, Royse C (2010) A review of local anesthetic cardiotoxicity and treatment with lipid emulsion. Local Reg Anesth 3:11–19. https://doi.org/10.2147/lra.s8814 Verlinde M, Hollmann MW, Stevens MF, Hermanns H, Werdehausen R, Lirk P (2016) Local anesthetic-induced neurotoxicity. Int J Mol Sci 17(3):339. https://doi.org/10.3390/ijms17030339 Perez-Castro R, Patel S, Garavito-Aguilar ZV, Rosenberg A, Recio-Pinto E, Zhang J et al (2009) Cytotoxicity of local anesthetics in human neuronal cells. Anesth Analg 108(3):997–1007. https://doi.org/10.1213/ane.0b013e31819385e1 Aburawi EH, Souid AK (2014) Inhibition of murine cardiomyocyte respiration by amine local anesthetics. Eur J Drug Metab Pharmacokinet 39(4):293–299. https://doi.org/10.1007/s13318-013-0159-4 Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109(2):180–187. https://doi.org/10.1097/ALN.0b013e31817f5b73 Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105(4):660–664. https://doi.org/10.1097/00000542-200610000-00008 Weng M, Chen W, Hou W, Li L, Ding M, Miao C (2016) The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: an updated meta-analysis. Oncotarget 7(12):15262–15273. https://doi.org/10.18632/oncotarget.7683 Sun Y, Li T, Gan TJ (2015) The effects of perioperative regional anesthesia and analgesia on cancer recurrence and survival after oncology surgery: a systematic review and meta-analysis. Reg Anesth Pain Med 40(5):589–598. https://doi.org/10.1097/AAP.0000000000000273 Chen WK, Miao CH (2013) The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies. PLoS ONE 8(2):e56540. https://doi.org/10.1371/journal.pone.0056540 Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C (2000) Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 10(2):165–169 de Oliveira GS, Ahmad S Jr, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ (2011) Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 36(3):271–7 Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C (2011) Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 107(2):164–170. https://doi.org/10.1093/bja/aer100 Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W (2011) Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth 106(6):814–822. https://doi.org/10.1093/bja/aer055 Li T, Chen L, Zhao H, Wu L, Masters J, Han C et al (2019) Both bupivacaine and levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro. J Anesth 33(1):17–25. https://doi.org/10.1007/s00540-018-2577-6 Bezu L, Wu Chuang A, Sauvat A, Humeau J, Xie W, Cerrato G et al (2022) Local anesthetics elicit immune-dependent anticancer effects. J Immunother Cancer 10(4):1–17. https://doi.org/10.1136/jitc-2021-004151 Zhang L, Hu R, Cheng Y, Wu X, Xi S, Sun Y et al (2017) Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A. Cell proliferation 50(5):1–8. https://doi.org/10.1111/cpr.12364 Li C, Gao S, Li X, Li C, Ma L (2018) Procaine inhibits the proliferation and migration of colon cancer cells through inactivation of the ERK/MAPK/FAK pathways by regulation of RhoA. Oncol Res 26(2):209–217. https://doi.org/10.3727/096504017X14944585873622 D’Agostino G, Saporito A, Cecchinato V, Silvestri Y, Borgeat A, Anselmi L et al (2018) Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration. Br J Anaesth 121(4):962–968. https://doi.org/10.1016/j.bja.2018.07.015 Sui H, Lou A, Li Z, Yang J. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.BMC cancer. 2019;19(1):233.doi: https://doi.org/10.1186/s12885-019-5431-9 Qin A, Liu Q, Wang J (2020) Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression. Drug Dev Res 81(6):700–707. https://doi.org/10.1002/ddr.21671 Villar-Garea A, Fraga MF, Espada J, Esteller M (2003) Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 63(16):4984–4989 Li YC, Wang Y, Li DD, Zhang Y, Zhao TC, Li CF (2018) Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer. J Cell Biochem 119(2):2440–2449. https://doi.org/10.1002/jcb.26407 Tada M, Imazeki F, Fukai K, Sakamoto A, Arai M, Mikata R et al (2007) Procaine inhibits the proliferation and DNA methylation in human hepatoma cells. Hep Intl 1(3):355–364. https://doi.org/10.1007/s12072-007-9014-5 Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H (2014) Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth 113(Suppl 1):i32–i38. https://doi.org/10.1093/bja/aeu201 Chen D, Yan Y, Xie J, Pan J, Chen Y, Li Q et al (2020) Amide-type local anesthetics may suppress tumor cell proliferation and sensitize human hepatocellular carcinoma cells to cisplatin via upregulation of RASSF1A expression and demethylation. J Cancer 11(24):7312–7319. https://doi.org/10.7150/jca.46630 Lirk P, Berger R, Hollmann MW, Fiegl H (2012) Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth 109(2):200–207. https://doi.org/10.1093/bja/aes128 Xia W, Wang L, Yu D, Mu X, Zhou X (2019) Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR520a3p/EGFR axis. Mol Med Rep 20(2):1333–1342. https://doi.org/10.3892/mmr.2019.10363 Ying B, Huang H, Li H, Song M, Wu S, Ying H (2017) Procaine inhibits proliferation and migration and promotes cell apoptosis in osteosarcoma cells by upregulation of MicroRNA-133b. Oncol Res 25(9):1463–70. https://doi.org/10.3727/096504017X14878518291077 Yin D, Liu L, Shi Z, Zhang L, Yang Y (2020) Ropivacaine inhibits cell proliferation, migration and invasion, whereas induces oxidative stress and cell apoptosis by circSCAF11/miR-145-5p axis in glioma. Cancer management and research 12:11145–11155. https://doi.org/10.2147/CMAR.S274975 Zhang H, Lin J, Hu T, Ren Z, Wang W, He Q (2019) Effect of miR-132 on bupivacaine-induced neurotoxicity in human neuroblastoma cell line. J Pharmacol Sci 139(3):186–192. https://doi.org/10.1016/j.jphs.2019.01.014 Sun H, Sun Y (2019) Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis. Artif cells nanomed biotechnol 47(1):2866–2874. https://doi.org/10.1080/21691401.2019.1636807 Zhang N, Xing X, Gu F, Zhou G, Liu X, Li B (2020) Ropivacaine inhibits the growth, migration and invasion of gastric cancer through attenuation of WEE1 and P13K/AKT signaling via miR-520a-3p. OncoTargets and therapy 13:5309–21 Arita K, Utsumi T, Kato A, Kanno T, Kobuchi H, Inoue B et al (2000) Mechanism of dibucaine-induced apoptosis in promyelocytic leukemia cells (HL-60). Biochem Pharmacol 60(7):905–915. https://doi.org/10.1016/s0006-2952(00)00406-8 Tsuchiya H, Mizogami M, Ueno T, Shigemi K (2012) Cardiotoxic local anesthetics increasingly interact with biomimetic membranes under ischemia-like acidic conditions. Biol Pharm Bull 35(6):988–992. https://doi.org/10.1248/bpb.35.988 Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ (2004) Mitochondrial injury and caspase activation by the local anesthetic lidocaine. Anesthesiology 101(5):1184–1194. https://doi.org/10.1097/00000542-200411000-00019 Dan J, Gong X, Li D, Zhu G, Wang L, Li F (2018) Inhibition of gastric cancer by local anesthetic bupivacaine through multiple mechanisms independent of sodium channel blockade. Biomed Pharmacotherapy = Biomed Pharmacotherapie 103:823–8. https://doi.org/10.1016/j.biopha.2018.04.106 Lu J, Xu SY, Zhang QG, Xu R, Lei HY (2011) Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways. Eur J Pharmacol 657(1–3):51–58. https://doi.org/10.1016/j.ejphar.2011.01.055 Gong X, Dan J, Li F, Wang L (2018) Suppression of mitochondrial respiration with local anesthetic ropivacaine targets breast cancer cells. J Thorac Dis 10(5):2804–2812. https://doi.org/10.21037/jtd.2018.05.21 Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D et al (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33–42. https://doi.org/10.1016/j.redox.2018.05.014 Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q et al (2017) Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology 126(5):868–881. https://doi.org/10.1097/ALN.0000000000001528 Bezu L, Kepp O, Kroemer G (2022) Immunogenic stress induced by local anesthetics injected into neoplastic lesions. Oncoimmunology 11(1):2077897. https://doi.org/10.1080/2162402X.2022.2077897 Freeman J, Crowley PD, Foley AG, Gallagher HC, Iwasaki M, Ma D et al (2018) Effect of perioperative lidocaine and cisplatin on metastasis in a murine model of breast cancer surgery. Anticancer Res 38(10):5599–5606. https://doi.org/10.21873/anticanres.12894 Zhang X, Pang W, Liu H, Wang J (2019) Lidocine potentiates the cytotoxicity of 5-fluorouracil to choriocarcinoma cells by downregulating ABC transport proteins expression. J Cell Biochem 120(10):16533–16542. https://doi.org/10.1002/jcb.28913 Li K, Yang J, Han X (2014) Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARbeta2 and RASSF1A demethylation. Int J Mol Sci 15(12):23519–23536. https://doi.org/10.3390/ijms151223519 Zheng Q, Peng X, Zhang Y (2020) Cytotoxicity of amide-linked local anesthetics on melanoma cells via inhibition of Ras and RhoA signaling independent of sodium channel blockade. BMC anesthesiology 20(1):43 1–9. https://doi.org/10.1186/s12871-020-00957-4 Zhu G, Zhang L, Dan J, Zhu Q (2020) Differential effects and mechanisms of local anesthetics on esophageal carcinoma cell migration, growth, survival and chemosensitivity. BMC Anesthesiol 20(1):126. https://doi.org/10.1186/s12871-020-01039-1 Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C et al (2019) Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nat Commun 10(1):1486. https://doi.org/10.1038/s41467-019-09415-3 Xie C, Duffy AG, Mabry-Hrones D, Wood B, Levy E, Krishnasamy V et al (2019) Tremelimumab in combination with microwave ablation in patients with refractory biliary tract cancer. Hepatology 69(5):2048–2060. https://doi.org/10.1002/hep.30482 Theurich S, Rothschild SI, Hoffmann M, Fabri M, Sommer A, Garcia-Marquez M et al (2016) Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Cancer Immunol Res 4(9):744–754. https://doi.org/10.1158/2326-6066.CIR-15-0156 Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D et al (2017) Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 66(3):545–551. https://doi.org/10.1016/j.jhep.2016.10.029